Zurich Cantonal Bank’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-26,661
Closed -$176K – 2560
2025
Q2
$176K Buy
26,661
+9,480
+55% +$67.2K ﹤0.01% 2189
2025
Q1
$157K Buy
17,181
+4,513
+36% +$45.1K ﹤0.01% 2218
2024
Q4
$133K Buy
+12,668
New +$150K ﹤0.01% 2332
2022
Q4
– Sell
-7,593
Closed -$53K – 2856
2022
Q3
$53K Hold
7,593
– – ﹤0.01% 2573
2022
Q2
$52K Buy
7,593
+5,454
+255% +$55.6K ﹤0.01% 2573
2022
Q1
$30K Buy
+2,139
New +$28.6K ﹤0.01% 2608

Other funds holding BVS

Zurich Cantonal Bank's BVS Position: Q3 2025 in Review

Zurich Cantonal Bank sold out of Bioventus (BVS) in Q3 2025, closing a stake of 26,661 shares — an estimated $176K sold.

Zurich Cantonal Bank first reported a position in BVS in Q1 2022 and held it in 6 quarters. The position peaked at $176K in Q2 2025. 135 funds tracked by Wall St. Rank hold BVS as of Q3 2025.

  • Zurich Cantonal Bank reported no remaining Bioventus position as of Q3 2025 after selling out during the quarter.
  • Zurich Cantonal Bank sold 26,661 Bioventus shares in Q3 2025, an estimated $176K.
  • Zurich Cantonal Bank first reported a position in Bioventus in Q1 2022 and held it in 6 quarters.
  • Zurich Cantonal Bank's Bioventus position peaked at $176K in Q2 2025.
  • 135 funds tracked by Wall St. Rank held Bioventus as of Q3 2025.

Based on Zurich Cantonal Bank's 13F filing for Q3 2025, filed 14 Nov 2025.